Cite
Resistance to epithelial growth factor receptor tyrosine kinase inhibitors in a patient with transformation from lung adenocarcinoma to small cell lung cancer: A case report.
MLA
Liying Fang, et al. “Resistance to Epithelial Growth Factor Receptor Tyrosine Kinase Inhibitors in a Patient with Transformation from Lung Adenocarcinoma to Small Cell Lung Cancer: A Case Report.” Oncology Letters, vol. 14, no. 1, July 2017, pp. 593–98. EBSCOhost, https://doi.org/10.3892/ol.2017.6229.
APA
Liying Fang, Jingwen Xia, Liang Dong, Xiujuan Zhang, Mengjie Niu, Tianxing Hang, Shengqing Li, Yaqin Chai, & Ying Li. (2017). Resistance to epithelial growth factor receptor tyrosine kinase inhibitors in a patient with transformation from lung adenocarcinoma to small cell lung cancer: A case report. Oncology Letters, 14(1), 593–598. https://doi.org/10.3892/ol.2017.6229
Chicago
Liying Fang, Jingwen Xia, Liang Dong, Xiujuan Zhang, Mengjie Niu, Tianxing Hang, Shengqing Li, Yaqin Chai, and Ying Li. 2017. “Resistance to Epithelial Growth Factor Receptor Tyrosine Kinase Inhibitors in a Patient with Transformation from Lung Adenocarcinoma to Small Cell Lung Cancer: A Case Report.” Oncology Letters 14 (1): 593–98. doi:10.3892/ol.2017.6229.